Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Consumer Resources

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Experts At European Parliament Session Outline Challenges In TB Drug Development

EurActiv: Developing countries urged to produce TB vaccines locally “Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease. Speaking at the European Parliament on Wednesday (21…

MSF Accepts Pneumonia Vaccine Donation, Bending Own Policy; Group Still Advocates For Fair Pricing

Devex: MSF bends donation policy for pneumonia vaccine “After years of refusing vaccine handouts from big pharmaceutical companies, international medical humanitarian group Médecins Sans Frontières is bending its policy to accept donations of the pneumococcal conjugate vaccine. … ‘We are not asking for charity from big pharmaceutical companies, but for…

Systematic Changes In Pricing, Procurement Must Occur For Universal Access To Affordable Vaccines

The Lancet: What are affordable vaccines? Editorial Board “…Although the world’s poorest countries are supported by Gavi, [a new report from Médecins Sans Frontières (MSF)] describes how a large group of middle-income countries, aid agencies, and Gavi-graduating countries are struggling to afford key vaccinations. … MSF calls on governments and…

Private Sector Must Join Governments In Providing Unprecedented Amount Of Humanitarian Aid

Project Syndicate: Aid in a World of Crisis António Guterres, U.N. High Commissioner for Refugees “…Protracted wars, environmental disasters, and state failure have stretched the international humanitarian aid system passed its breaking point. If the UNHCR and other relief agencies are to address the unprecedented amount of human need, they…

Bureaucratic Delays Keep India’s Vulnerable From Receiving Life-Saving TB Treatment

Wall Street Journal: Inside India: The Deadly Effects of Red Tape Getta Anand, senior writer for the Wall Street Journal based in Mumbai “Red tape and over-regulation can kill. As Prime Minister Narendra Modi fights to loosen bureaucrats’ stifling grip on the economy, he also needs to ease Indians’ access…

7 Key Challenges Face Ebola Vaccine Developers, Stakeholders

The Lancet: Is the world ready for an Ebola vaccine? Bruce Y. Lee of the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health and colleagues “…We propose seven key challenges to be considered early in Ebola vaccine development that will help stakeholders prepare and allow developers…

China Approves New Polio Vaccine, As Beijing Pushes To Lead Innovative Drug Market

Reuters: China approves new polio vaccine, shows innovative muscle “China has approved a new polio vaccine, the first of its kind to be produced in the country, a month after local authorities gave the green light for a home-grown Ebola vaccine amid Beijing’s push to become a world leader in…

India Rejects Gilead’s Hepatitis C Drug Patent Request; Decision Will Allow Local Companies To Make Generic Versions

Financial Times: India spurns Gilead over hepatitis C patent “India’s patent controller has rejected a patent application from Gilead Sciences for a key compound for its blockbuster hepatitis C drug Sovaldi, a refusal that activists said would allow Indian companies immediately to start producing cheap generic versions of the medicine…”…

Developing, Testing Ebola Vaccines Presents Major Challenges, Report Says

News services discuss a new report released Monday by the Wellcome Trust and CIDRAP titled, “Fast-Track Development of Ebola Vaccines: Principles and Target Product Criteria.” CIDRAP News: Report maps complex challenges to Ebola vaccine efforts “As experimental Ebola vaccines start to head toward large clinical trials in Africa, a report…